| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/24/2011 | EP2358365A1 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives |
| 08/24/2011 | EP2358364A1 Therapeutics for neurological disorders |
| 08/24/2011 | EP2358362A1 Stabilized nicotine chewing gum |
| 08/24/2011 | EP2358361A1 Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate |
| 08/24/2011 | EP2358360A1 Prolonged release formulations comprising an 2 -oxo- 1 -pyrrolidine derivative |
| 08/24/2011 | EP2358357A1 Process for recovering florfenicol from pharmaceutical compositions |
| 08/24/2011 | EP2358356A1 Sustained release systems of ascorbic acid phosphate |
| 08/24/2011 | EP2358355A1 Pharmaceutical composition of a potent hcv inhibitor for oral administration |
| 08/24/2011 | EP2358353A1 Aerosol formulation for the inhalation of beta agonists |
| 08/24/2011 | EP2358351A1 Drug delivery system |
| 08/24/2011 | EP2358350A1 Aerosol formulation for the inhalation of beta agonists |
| 08/24/2011 | EP2358349A2 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| 08/24/2011 | EP2358220A1 Reducing astringency in compositions containing phenolic compounds |
| 08/24/2011 | EP2358216A1 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
| 08/24/2011 | EP2358204A1 Organic compounds |
| 08/24/2011 | EP2358203A1 Platinum acridine anti-cancer compounds and methods thereof |
| 08/24/2011 | EP2358202A1 Benzimidazole and aza-benzimidazole carboxamides |
| 08/24/2011 | EP2358200A1 Substituted bicyclic amines for the treatment of diabetes |
| 08/24/2011 | EP2358199A2 Improving cancer therapy by docetaxel and granulocyte colony-stimulating factor (g-csf) |
| 08/24/2011 | EP2358198A1 Hydroxyethylamino sulfonamide derivatives |
| 08/24/2011 | EP2252286B1 Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria |
| 08/24/2011 | EP2152702B1 Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer |
| 08/24/2011 | EP1951687B1 N-hydroxyamide derivatives and use thereof |
| 08/24/2011 | EP1948652B1 Glucokinase activators |
| 08/24/2011 | EP1948177B1 Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
| 08/24/2011 | EP1940818B1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 08/24/2011 | EP1928424B1 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof |
| 08/24/2011 | EP1912949B1 Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| 08/24/2011 | EP1910366B1 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 08/24/2011 | EP1897549B1 Radical scavenger and active oxygen eliminating agent |
| 08/24/2011 | EP1867332B1 Pharmaceutical composition and method using antifungal agent in combination |
| 08/24/2011 | EP1856095B1 Quinazoline derivatives as tyrosine kinase inhibitors |
| 08/24/2011 | EP1836164B1 11c-labeled benzyl-lactam compounds and their use as imaging agents |
| 08/24/2011 | EP1831208B1 Quaternary ammonium salts as m3 antagonists |
| 08/24/2011 | EP1829887B1 Cpg single-strand deoxynucleotides for use as adjuvant |
| 08/24/2011 | EP1827409B1 Rasagiline orally disintegrating compositions |
| 08/24/2011 | EP1786815B1 Spiro compounds and methods for the modulation of chemokine receptor activity |
| 08/24/2011 | EP1776359B1 Piperidine derivatives as renin inhibitors |
| 08/24/2011 | EP1773451B1 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms |
| 08/24/2011 | EP1758590B1 Use of a detergent for the non-surgical removal of fat |
| 08/24/2011 | EP1755590B1 Combination of glycopyrrolate and a beta2 adrenoceptor agonist |
| 08/24/2011 | EP1737439B1 Calcium salts for the treatment of psoriasis, dermatitis and dandruff |
| 08/24/2011 | EP1706102B1 Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them |
| 08/24/2011 | EP1684736B1 Dna damage repair inhibitors for treatment of cancer |
| 08/24/2011 | EP1670767B1 Resolution of a narwedine amide derivative |
| 08/24/2011 | EP1583737B1 Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester |
| 08/24/2011 | EP1581184B1 Veterinary compositions for treating mastitis |
| 08/24/2011 | EP1572128B1 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/24/2011 | EP1558616B2 Meso-substituted porphyrins |
| 08/24/2011 | EP1553948B1 Combination of imatnib and a histone deacetylase inhibitor for the treatment of leukemia |
| 08/24/2011 | EP1537868B1 Antifungal medicinal compositions |
| 08/24/2011 | EP1536783B2 Solid formulations comprising an indolinone compound |
| 08/24/2011 | EP1531843B1 Method for treating cervical cancer |
| 08/24/2011 | EP1506774B1 Smooth muscle peristole inhibitor |
| 08/24/2011 | EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 08/24/2011 | EP1490338B1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 08/24/2011 | EP1480603B1 Use of sugar esters in cosmetic preparations |
| 08/24/2011 | EP1465882B1 Hetrocyclic modulators of nuclear receptors |
| 08/24/2011 | EP1423404B1 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/24/2011 | EP1399148B1 Multifunctional carbonates and derivatives |
| 08/24/2011 | EP1369106B1 Emulsion composition |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | EP1104303B1 Carbohydrate or 2'-modified oligonucleotides having alternating internucleoside linkages |
| 08/24/2011 | EP1047420B2 Modulation of hair growth |
| 08/24/2011 | EP1023067B2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 08/24/2011 | CN1976923B Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation |
| 08/24/2011 | CN1946656B Methods, compositions, and apparatuses for forming macrocyclic compounds |
| 08/24/2011 | CN1929816B Pharmaceutical compositions comprising midazolam in a high concentration |
| 08/24/2011 | CN1926114B Processes for preparing substituted N-aryl-N'-[3-(1H-pyrazol-5-yl) phenyl] ureas and intermediates thereof |
| 08/24/2011 | CN1775289B Multi vitamin oral disintegrating tablet formulation and its preparing method |
| 08/24/2011 | CN1688295B Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers |
| 08/24/2011 | CN1404389B Timed pulsatile drug delivery systems |
| 08/24/2011 | CN102164942A Triterpenoid compounds and methods of use thereof |
| 08/24/2011 | CN102164941A Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring |
| 08/24/2011 | CN102164940A TGR5 modulators and methods of use thereof |
| 08/24/2011 | CN102164928A Hepatitis c virus inhibitors |
| 08/24/2011 | CN102164927A Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine D3 receptors |
| 08/24/2011 | CN102164925A Tricyclic oxazolidinone antibiotic compounds |
| 08/24/2011 | CN102164924A 3H-imidaz0 [4, 5-B] pyridine- 6 -carboxamides as anti -inflammatory agents |
| 08/24/2011 | CN102164922A 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti -inflammatory agents |
| 08/24/2011 | CN102164920A Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
| 08/24/2011 | CN102164919A Oxazolidinyl antibiotics |
| 08/24/2011 | CN102164918A Solid pharmaceutical composition |
| 08/24/2011 | CN102164917A Compounds which selectively modulate the CB2 receptor |
| 08/24/2011 | CN102164916A Compounds which selectively modulate the CB2 receptor |
| 08/24/2011 | CN102164915A 2-benzothiophenyl-and 2-naphthyl-Oxazolidinones and their azaisostere analogues as antibacterial agents |
| 08/24/2011 | CN102164914A Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors |
| 08/24/2011 | CN102164913A Crystalline forms of a 3-pyrrole substituted 2-indolinone malate salt |
| 08/24/2011 | CN102164912A Process for making quinolone compounds |
| 08/24/2011 | CN102164911A 1H-benzimidazole-5-carboxamides as anti-inflammatory agents |
| 08/24/2011 | CN102164910A Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-CARBOXAMIDINE derivatives having CB1-antagonistic activity |
| 08/24/2011 | CN102164909A Pyrine or pyrazine derivatives for treating HCV |
| 08/24/2011 | CN102164908A Selective estrogen repector modulator for the treatment of osteoarthritis |
| 08/24/2011 | CN102164905A Compounds as hypoxia mimetics, and compositions, and uses thereof |
| 08/24/2011 | CN102164904A 6-substituted isoflavonoid compounds and uses thereof |
| 08/24/2011 | CN102164902A 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 08/24/2011 | CN102164900A 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives |
| 08/24/2011 | CN102164899A 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as FXR modulators against dyslipidemia and related diseases |